HK1202120A1 - Improved process for preparing an intermediate of the macrocyclic protease inhibitor tmc 435 - Google Patents
Improved process for preparing an intermediate of the macrocyclic protease inhibitor tmc 435 Download PDFInfo
- Publication number
- HK1202120A1 HK1202120A1 HK15102687.7A HK15102687A HK1202120A1 HK 1202120 A1 HK1202120 A1 HK 1202120A1 HK 15102687 A HK15102687 A HK 15102687A HK 1202120 A1 HK1202120 A1 HK 1202120A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compound
- dichloro
- ruthenium
- bis
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11187025.9 | 2011-10-28 | ||
| EP11187025 | 2011-10-28 | ||
| PCT/IB2012/055900 WO2013061285A1 (en) | 2011-10-28 | 2012-10-26 | Improved process for preparing an intermediate of the macrocyclic protease inhibitor tmc 435 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1202120A1 true HK1202120A1 (en) | 2015-09-18 |
Family
ID=47221505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15102687.7A HK1202120A1 (en) | 2011-10-28 | 2012-10-26 | Improved process for preparing an intermediate of the macrocyclic protease inhibitor tmc 435 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8981082B2 (enExample) |
| EP (1) | EP2771339B1 (enExample) |
| JP (1) | JP6231482B2 (enExample) |
| KR (1) | KR20140086967A (enExample) |
| CN (1) | CN104053658B (enExample) |
| AR (1) | AR088568A1 (enExample) |
| AU (1) | AU2012327934B2 (enExample) |
| BR (1) | BR112014009849A2 (enExample) |
| CA (1) | CA2848377A1 (enExample) |
| CL (1) | CL2014001043A1 (enExample) |
| EA (1) | EA201490892A1 (enExample) |
| ES (1) | ES2671732T3 (enExample) |
| HK (1) | HK1202120A1 (enExample) |
| IL (1) | IL231892A (enExample) |
| MX (1) | MX347650B (enExample) |
| TW (1) | TWI574960B (enExample) |
| WO (1) | WO2013061285A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41812A (fr) | 2015-03-27 | 2018-01-30 | Janssen Pharmaceuticals Inc | Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc |
| WO2017064680A1 (en) * | 2015-10-16 | 2017-04-20 | Lupin Limited | An improved process for the preparation of simeprevir sodium and intermediate thereof |
| CN109846883A (zh) * | 2017-11-30 | 2019-06-07 | 常州寅盛药业有限公司 | 苯并呋喃衍生物与tmc435联合用药物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1771257A (zh) * | 2003-04-10 | 2006-05-10 | 贝林格尔·英格海姆国际有限公司 | 通过钌络合物催化的易位反应制备大环化合物的方法 |
| PE20070211A1 (es) * | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
| ATE510846T1 (de) * | 2005-09-09 | 2011-06-15 | Boehringer Ingelheim Int | Cyclisierendes metatheseverfahren zur herstellung von makrocyclischen peptiden |
| US8193346B2 (en) | 2007-12-06 | 2012-06-05 | Enanta Pharmaceuticals, Inc. | Process for making macrocyclic oximyl hepatitis C protease inhibitors |
| AU2009278075B2 (en) * | 2008-08-07 | 2013-07-04 | F. Hoffmann-La Roche Ag | Process for the preparation of a macrocycle |
| BRPI0923393B1 (pt) | 2008-12-23 | 2018-06-19 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | "processos para preparar um inibidor de protease de hcv macrocíclico e intermediários e uso". |
-
2012
- 2012-10-26 MX MX2014005070A patent/MX347650B/es active IP Right Grant
- 2012-10-26 JP JP2014537794A patent/JP6231482B2/ja not_active Expired - Fee Related
- 2012-10-26 CN CN201280052692.3A patent/CN104053658B/zh not_active Expired - Fee Related
- 2012-10-26 BR BR112014009849A patent/BR112014009849A2/pt not_active IP Right Cessation
- 2012-10-26 US US14/350,138 patent/US8981082B2/en not_active Expired - Fee Related
- 2012-10-26 KR KR1020147009887A patent/KR20140086967A/ko not_active Ceased
- 2012-10-26 AR ARP120104040A patent/AR088568A1/es unknown
- 2012-10-26 EA EA201490892A patent/EA201490892A1/ru unknown
- 2012-10-26 EP EP12790677.4A patent/EP2771339B1/en active Active
- 2012-10-26 WO PCT/IB2012/055900 patent/WO2013061285A1/en not_active Ceased
- 2012-10-26 HK HK15102687.7A patent/HK1202120A1/xx unknown
- 2012-10-26 CA CA2848377A patent/CA2848377A1/en not_active Abandoned
- 2012-10-26 AU AU2012327934A patent/AU2012327934B2/en not_active Ceased
- 2012-10-26 ES ES12790677.4T patent/ES2671732T3/es active Active
- 2012-10-26 TW TW101139616A patent/TWI574960B/zh not_active IP Right Cessation
-
2014
- 2014-04-03 IL IL231892A patent/IL231892A/en not_active IP Right Cessation
- 2014-04-24 CL CL2014001043A patent/CL2014001043A1/es unknown
-
2015
- 2015-02-09 US US14/616,770 patent/US9328108B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EA201490892A1 (ru) | 2014-08-29 |
| US20150152098A1 (en) | 2015-06-04 |
| KR20140086967A (ko) | 2014-07-08 |
| BR112014009849A2 (pt) | 2016-07-05 |
| AU2012327934A1 (en) | 2014-03-20 |
| AU2012327934B2 (en) | 2017-06-01 |
| US9328108B2 (en) | 2016-05-03 |
| US20140235852A1 (en) | 2014-08-21 |
| IL231892A (en) | 2017-09-28 |
| TW201323423A (zh) | 2013-06-16 |
| TWI574960B (zh) | 2017-03-21 |
| ES2671732T3 (es) | 2018-06-08 |
| EP2771339B1 (en) | 2018-04-18 |
| CN104053658A (zh) | 2014-09-17 |
| IL231892A0 (en) | 2014-05-28 |
| CN104053658B (zh) | 2018-03-13 |
| MX347650B (es) | 2017-05-05 |
| CL2014001043A1 (es) | 2014-07-25 |
| JP6231482B2 (ja) | 2017-11-15 |
| AR088568A1 (es) | 2014-06-18 |
| EP2771339A1 (en) | 2014-09-03 |
| JP2014530901A (ja) | 2014-11-20 |
| WO2013061285A1 (en) | 2013-05-02 |
| MX2014005070A (es) | 2014-08-22 |
| CA2848377A1 (en) | 2013-05-02 |
| US8981082B2 (en) | 2015-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5789260B2 (ja) | Ｃ型肝炎ウイルスのプロテアーゼ阻害薬の調製方法 | |
| CN111741769A (zh) | 一种多功能化合物、其制备方法及其在医药上的应用 | |
| KR102654709B1 (ko) | 치환된 트리시클릭 헤테로시클릭 화합물 | |
| KR102696304B1 (ko) | Tnf의 억제제로서 유용한 헤테로시클릭 화합물 | |
| KR102519536B1 (ko) | 트리시클릭 회전장애이성질체 화합물 | |
| WO2005087767A1 (en) | Hiv integrase inhibitors | |
| CN110582500A (zh) | 双并环类核衣壳抑制剂和其作为药物用于治疗乙型肝炎的用途 | |
| KR20110066224A (ko) | Ｈｉｖ 인테그라제 억제제 | |
| JP7604018B2 (ja) | 化合物、その薬学的に許容される塩又は立体異性体、及びその使用 | |
| TW202317514A (zh) | 新穎方法 | |
| HK1202120A1 (en) | Improved process for preparing an intermediate of the macrocyclic protease inhibitor tmc 435 | |
| Sośnicki et al. | Scope and limitations of the synthesis of functionalized quinolizidinones and related compounds by a simple precursor approach via addition of lithium allylmagnesates to 2-pyridones and RCM as key steps | |
| CN110423265A (zh) | 一种环肽类trf2抑制剂的制备方法和用途 | |
| CN101314595B (zh) | 芳烃连接的多聚胺类大环衍生物、其制备方法和医疗用途 | |
| Magura | Photochemical synthesis of dihydroquinolinones and their investigation toward macrocycle synthesis via ring expansion | |
| KR102899506B1 (ko) | 치환된 헤테로사이클 융합 감마-카르볼린 합성 | |
| EP3334738A1 (en) | 2-amino-7a-phenyl-3,4,4a,5,7,7a-hexahydrofuro[3,4-b]pyridines as bace1 inhibitors | |
| Enßle et al. | Rhodium (II)-catalyzed intramolecular carbonyl ylide formation of α-diazo-β-ketoesters derived from N-phthaloyl-α-amino acids. | |
| Yamanushkin | Directing effect of Amide Function in Diastereoselective Reactions of Cyclopropenes and Cyclopropanes | |
| HK40050245A (en) | Cell necrosis inhibitor, preparation method therefor and use thereof | |
| Brown et al. | A synthetic study of dibenzo-aromatic macrolactams | |
| Ashraf | Studies towards the synthesis of fumitremorgin C and a mechanistic study of the Pictet-Spengler reaction | |
| HK1125096B (en) | Arene linked polyamine macrocylicderivatives, preparation method and pharmaceutical use thereof | |
| HK1125096A1 (en) | Arene linked polyamine macrocylicderivatives, preparation method and pharmaceutical use thereof |